Osteogenesis imperfecta calls for caution - PubMed

Comment

Osteogenesis imperfecta calls for caution

J C Marini. Nat Med. 1999 May.

Comment on

• Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

  Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Horwitz EM, et al. Nat Med. 1999 Mar;5(3):309-13. doi: 10.1038/6529. Nat Med. 1999. PMID: 10086387

Similar articles

• Osteogenesis imperfecta calls for caution.

  Bishop NJ. Bishop NJ. Nat Med. 1999 May;5(5):466-7. doi: 10.1038/8528. Nat Med. 1999. PMID: 10229208 No abstract available.

• Mesenchymal stem cells: no longer second class marrow citizens.

  Gerson SL. Gerson SL. Nat Med. 1999 Mar;5(3):262-4. doi: 10.1038/6470. Nat Med. 1999. PMID: 10086373 No abstract available.

• Filling the gaps: osteogenesis imperfecta.

  Graul AI. Graul AI. Drug News Perspect. 2005 Jul-Aug;18(6):400-1. Drug News Perspect. 2005. PMID: 16247517 No abstract available.

• [Osteogenesis imperfecta--a congenital brittleness of bones].

  Kaitila I, Kuurila K, Kallio P. Kaitila I, et al. Duodecim. 2001;117(21):2195-202. Duodecim. 2001. PMID: 12184207 Review. Finnish. No abstract available.

• Osteogenesis imperfecta: an overview.

  Clark C. Clark C. Nurs Stand. 2001 Oct 17-23;16(5):47-52; quiz 53, 55. doi: 10.7748/ns2001.10.16.5.47.c3100. Nurs Stand. 2001. PMID: 11977799 Review.

Cited by

• Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche.

  Hofmann TJ, Otsuru S, Marino R, Rasini V, Veronesi E, Murgia A, Lahti J, Boyd K, Dominici M, Horwitz EM. Hofmann TJ, et al. Mol Ther. 2013 Jun;21(6):1224-31. doi: 10.1038/mt.2013.36. Epub 2013 Apr 16. Mol Ther. 2013. PMID: 23587920 Free PMC article.

• Severe osteogenesis imperfecta: new therapeutic options?

  Smith R. Smith R. BMJ. 2001 Jan 13;322(7278):63-64. BMJ. 2001. PMID: 11154605 Free PMC article. No abstract available.

• Osteogenesis imperfecta: practical treatment guidelines.

  Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tatò L. Antoniazzi F, et al. Paediatr Drugs. 2000 Nov-Dec;2(6):465-88. doi: 10.2165/00128072-200002060-00005. Paediatr Drugs. 2000. PMID: 11127846 Review.

• High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta.

  Cabral WA, Marini JC. Cabral WA, et al. Am J Hum Genet. 2004 Apr;74(4):752-60. doi: 10.1086/383252. Epub 2004 Mar 11. Am J Hum Genet. 2004. PMID: 15024692 Free PMC article.

• Current and emerging treatments for the management of osteogenesis imperfecta.

  Monti E, Mottes M, Fraschini P, Brunelli P, Forlino A, Venturi G, Doro F, Perlini S, Cavarzere P, Antoniazzi F. Monti E, et al. Ther Clin Risk Manag. 2010 Sep 7;6:367-81. doi: 10.2147/tcrm.s5932. Ther Clin Risk Manag. 2010. PMID: 20856683 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Medical

  • MedlinePlus Health Information